Rasagiline Mesylate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Rasagiline Mesylate drug offered from Mylan Pharmaceuticals Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | rasagiline mesylate |
| SUBSTANCE NAME: | RASAGILINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-26 |
| END MARKETING DATE: | 0000-00-00 |
Rasagiline Mesylate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rasagiline Mesylate from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2017-05-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-1270_45e010f2-7e6b-41f5-b043-727bbda2232e |
| PRODUCT NDC: | 0378-1270 |
| APPLICATION NUMBER: | ANDA201971 |
Other RASAGILINE MESYLATE Pharmaceutical Manufacturers / Labelers:
